Salute e Benessere

Remote Patient Monitoring Market to Grow at a CAGR of 19.0% from 2025 to 2032 |…

Get a Free Sample Report - https://www.skyquestt.com/sample-request/remote-patient-monitoring-market Get a Free Sample Report -https://www.skyquestt.com/sample-request/remote-patient-monitoring-market Remote Patient Monitoring Market Key Growth Drivers Remote monitoring of patients has benefitted in obtaining real-time patient data for illnesses, such as chronic obstructive pulmonary disease (COPD), cancer, or diabetes, resulting in timely management of the diseases. Implementation...
PR Newswire
30/07/2025

Biosimilars Market is Estimated to Reach USD 88.9 Billion by 2032 | SkyQuest…

Get a Free Sample Report - https://www.skyquestt.com/sample-request/biosimilars-market Get a Free Sample Report - https://www.skyquestt.com/sample-request/biosimilars-market Biosimilars Market Key Growth Drivers: The growing burden of rising obesity rates, poor diets, and chronic physical inactivity has compelled many healthcare systems to look for different ways to provide patients with affordable treatments. According to WHO estimates, being overweight or obese will cause more...
PR Newswire
30/07/2025

Dental Imaging Market Worth US$4.69 billion by 2030 with 7.5% CAGR |…

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=109621591 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=109621591 Browse in-depth TOC on "Dental Imaging Market" 150 - Tables 45 - Figures 250 - Pages By product,the dental imaging market has been divided into two main categories: extraoral and intraoral imaging systems. Among the extraoral imaging systems segment, panoramic imaging systems represented the...
PR Newswire
30/07/2025

Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of…

"The remarkable part of this lawsuit is that Egg Medical never sold any product that fell within the scope of Rampart's now-rejected patent claims," said Robert F. Wilson, MD, CEO of Egg Medical. "Egg Medical respects prior intellectual property. The USPTO rejecting the claims in Rampart's asserted '056 patent validates what we have been saying all along." "The remarkable part of this lawsuit is that Egg Medical never sold any product that fell within the scope of…
PR Newswire
30/07/2025

C-Parts Market to reach USD 212.79 billion by 2031, due to an Increase in Orders…

The c-parts market outlook remains positive, as it is well-positioned to serve the requirements of end-user industries such as construction, aerospace & defense, oil & gas, agriculture, and manufacturing. Manufacturers are under constant pressure to maintain the overall operational costs while improving efficiency. Thus, the demand for durable and high-strength industrial components is increasing to avoid additional operational costs, machinery downtime, and stricter industrial norms…
PR Newswire
30/07/2025

Biosensors Market Set to Reach Valuation of US$ 75.84 Billion By 2033 | New Wave…

Request PDF Sample Pages: https://www.astuteanalytica.com/request-sample/biosensors-market Request PDF Sample Pages:https://www.astuteanalytica.com/request-sample/biosensors-market Advanced wearables now incorporate a wider array of sensors, tracking biometrics like EMG, EEG, ECG, heart rate, blood pressure, and temperature. A major frontier in the biosensors market is non-invasive glucose monitoring. One novel optical device using 660 nm light achieved a Mean Absolute Relative...
PR Newswire
30/07/2025

Emerald Clinical Trials Confirms CEO Transition and Continuity Plan

"We thank Mary for her contributions," said Sean Carney, Chair of the Board. "Emerald Clinical Trials is a leading CRO with global capabilities and with Glenn stepping in as Interim CEO, we are confident in our ability to maintain momentum and deliver for our clients," Sean Carney said. "We thank Mary for her contributions," saidSean Carney, Chair of the Board. "Emerald Clinical Trials is a leading CRO with global capabilities and with Glenn stepping in as…
PR Newswire
30/07/2025

MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of…

MAGENTIQ EYE's FDA- and CE-approved software, MAGENTIQ-COLO™, enhances polyp detection and analysis capabilities during colonoscopies, significantly improving adenoma detection rates. MAGENTIQ-COLO also offers real-time insights, and its CE-approved version includes polyp-size category and type estimation, and advanced AI-generated reports. MAGENTIQ EYE's FDA- and CE-approved software,MAGENTIQ-COLO™, enhances polyp detection and analysis capabilities during colonoscopies, significantly...
PR Newswire
30/07/2025

Teva's Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025…

On track for 30% operating profit margin by 2027 in line with our Pivot to Growth Strategy.Q2 2025 shows 10 thconsecutive quarter of year-over-year (YoY) revenue growth; Revenues of $4.2 billion, +1% in local currencyterms (“LC“)excluding Japan BV revenues; United States segment +2%; Europe segment +3% in LC; International Markets segment -4% inLCand excluding Japan BV revenues.Innovative portfolio continues to fuel strong growth and provide value to diverse and critical patient...
Nasdaq GlobeNewswire
30/07/2025

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025: SNAP BENEFITS…

The findings highlight the potential of food assistance programs to support cognitive health in the aging population and point to the need for additional efforts to reduce disparities in cognitive aging across different racial and ethnic groups, the researchers said. They also underscore the need for public health policies that ensure equitable access to programs like SNAP, which helps low-income individuals and families buy food, particularly for populations that may face additional barriers to…
PR Newswire
30/07/2025

KFSHRC Advances Robotic Surgery with a Successful Ivor Lewis Esophagectomy

The procedure was led by Dr. Khalid Aldaghri, Consultant in bariatric, upper gastrointestinal, and robotic surgery at KFSHRC. Utilizing the Ivor Lewis technique, a complex and technically demanding procedure involving two phases. The abdominal phase involved stomach mobilization and creation of a gastric conduit. This was followed by the thoracic phase, in which the diseased esophagus was resected and the conduit is robotically connected within the chest.Precision in the robotic system...
Nasdaq GlobeNewswire
30/07/2025

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic…

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis Dr. Falk Pharma GmbH, a research-based pharmaceutical company specializing in digestive and metabolic medicine, Allianthera (Suzhou) Biopharmaceuticals Co., Ltd., and its affiliate Allianthera Boston, Inc., a clinical stage...
Nasdaq GlobeNewswire
30/07/2025

Leading European Shipbuilder Selects Aino’s SaaS Platform

Aino Health AB (publ) has signed an agreement with one of Europe’s leading shipbuilding companies for the implementation of the Aino SaaS platform. The agreement covers 2,000 employees and aims to strengthen the customer’s proactive work ability management and employee well-being initiatives. “We are proud that our platform will support this organization in improving work ability and reducing health-related risks across their operations,” says Jyrki Eklund, CEO of Aino Health. Through the...
Nasdaq GlobeNewswire
30/07/2025

Casino Group: Release of the H1 2025 presentation

RELEASE OF THE HALF YEAR 2025RESULTS PRESENTATION The Group has released its half year 2025 results presentation on its website. It is available at this link: https://www.groupe-casino.fr/wp-content/uploads/2025/07/2025-07-30-H1-2025-Results-Presentation.pdfAnalyst and investor contactsCharlotte Izabel +33 (0)6 89 19 88 33 [email protected] Relations +33 (0)1 53 65 24 [email protected] Press contactsCorporate...
Nasdaq GlobeNewswire
30/07/2025

Casino Group: Q2 SALES AND H1 2025 RESULTS

Q2 SALES AND H1 2025 RESULTS The New Casino: an improving first half-yearGrowth in net sales: +2.4% LFL in Q2 and +0.5% in H1 Supported by a more favourable market environment in Q2 and the initial results of its “Renouveau 2028” strategic plan, the Group is back to growth for the first time since its financial restructuring, with a second-quarter rise across all convenience brands.Roll out of the newstore concepts 32 Franprix stores remodelled with the ‘ Oxygène ’ concept...
Nasdaq GlobeNewswire
30/07/2025

AB Science receives regulatory approval from European countries to initiate…

PRESS RELEASEAB SCIENCE RECEIVES REGULATORY APPROVAL FROM EUROPEAN COUNTRIES TO INITIATE THIRD STAGE OF PHASE I/II STUDY COMBINING ITS MOLECULE AB8939 WITH VENETOCLAX FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIATHE COMBINATION OF AB8939 TARGETING MICROTUBULE AND STEM CELLS AND VENETOCLAX TARGETING BCL-2 SHOWS POTENTIAL SYNERGISTIC EFFICACY AND GOOD HEMATOLOGICAL TOLERANCE COMPARED WITH STANDARD OF CARE CHEMOTHERAPIES, IN PARTICULAR IN THE POOR RESPONDERS TO STANDARD OF CARE...
Nasdaq GlobeNewswire
30/07/2025

Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec…

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASEProposed transaction would seamlessly align with Sandoz strategic objective of capitalizing on projected USD 300 billion biosimilar market opportunity over next 10 years[1]Intended acquisition would reinforce in-house biosimilar development and manufacturing capabilities, while creating additional strategic flexibilitySandoz would acquire Just-Evotec Biologics (JEB) activities in Toulouse, France,...
Nasdaq GlobeNewswire
30/07/2025

Photocure ASA: Results for the second quarter of 2025

The company continued to execute on its plan to expand blue light cystoscopy use in Q2 2025 with the installation of 12 new Saphira™ towers in the U.S. — 3 new accounts and 9 blue light tower upgrades. With the increasing momentum provided by ForTec's mobile solution, Photocure had 359 active accounts in the U.S. at the end of the quarter, an increase of 24% versus the second quarter of 2024. The company continued to execute on its plan to expand blue light cystoscopy use in Q2 2025 with the...
PR Newswire
30/07/2025

Strong sales acceleration of QUVIVIQ drives Idorsia toward profitability – H1…

Ad hoc announcement pursuant to Art. 53 LR QUVIVIQ™ (daridorexant): Strong performance and sales acceleration with total net sales of CHF 58 million in H1 2025 and increase of 145% compared to the same period in 2024, largely driven by sales in Europe. NDA approval with Simcere in China.Aprocitentan (TRYVIO/JERAYGO) commercial opportunity significantly improved with REMS removal and very positive real-world experience – engaging in partnership discussions.Net revenue H1 2025 of CHF 131...
Nasdaq GlobeNewswire
30/07/2025

Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan…

Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myelomaDesignation granted for IgG1-based GPRC5D monoclonal antibody for the potential treatment of patients with relapsed or refractory multiple myelomaParis, July 30, 2025.The US Food and Drug Administration (FDA) has granted orphan drug designation to SAR446523, an IgG1-based Antibody-Dependent Cellular Cytotoxicity-enhanced (ADCC) monoclonal antibody (mAb) targeting G-protein...
Nasdaq GlobeNewswire
30/07/2025

HIMSS partners with WHX Tech to advance digital health transformation in the…

The partnership with Informa Markets and WHX provides a new platform for HIMSS to share critical insights, education and networking for healthcare providers, governments, startups and health services organisations worldwide. The partnership with Informa Markets and WHX provides a new platform for HIMSS to share critical insights, education and networking for healthcare providers, governments, startups and health services organisations worldwide. "TheMiddle Eastis rapidly becoming an...
PR Newswire
30/07/2025

Triple-Negative Breast Cancer Market Gearing Up for Impressive Growth at a CAGR…

Key Takeaways from the Triple-Negative Breast Cancer Market Report Key Takeaways from the Triple-Negative Breast Cancer Market Report Discover the TNBC new treatment @New Treatments for TNBC Triple-Negative Breast Cancer Market Dynamics The triple-negative breast cancer market dynamics are expected to change in the coming years. Combining chemotherapy, immunotherapy, and targeted therapies, such asTALZENNA and TRODELVY, offers enhanced disease control and expands...
PR Newswire
29/07/2025

Information on the total number of voting rights and shares

REGULATED INFORMATIONInformation on the total number of voting rights and sharesMont-Saint-Guibert(Belgium), July 29, 2025 , 10:45 pm CET / 4:45 pm ET –In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 6,432,066.28 Total number of securities carrying voting rights: 37,441,140 (all ordinary...
Nasdaq GlobeNewswire
29/07/2025

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

NyxoahtoReleaseSecond Quarter 2025 Financial Results on August 18, 2025Mont-Saint-Guibert, Belgium – Tuesday July 29, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (EuronextBrussels/Nasdaq:NYXH)(“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for the second quarter of 2025 on Monday, August 18, 2025. Company management will host a...
Nasdaq GlobeNewswire
29/07/2025
Altri  Comunicati